Ocular Signs and Symptoms in Glaucoma Patients Switched From Latanoprost 0.005% to Preservative Free Tafluprost Eye Drops
Completed
Santen Oy
Phase 3
2008-01-01
The purpose of this study is to investigate if changes in ocular signs and symptoms occur in
patients with ocular hypertension or glaucoma when they switch from latanoprost 0.005%
(Xalatan) to preservative free Tafluprost eye drops.
Pharmacodynamics of Tafluprost 0.0015% Eye Drops: a Comparison Between the Preserved and Unpreserved Formulation
Completed
Santen Oy
Phase 3
2005-09-01
The objective of this study is to investigate the pharmacodynamics (as expressed in
intraocular pressure [IOP]) of two formulations of tafluprost 0.0015% eyedrops (preserved and
unpreserved) in patients with open-angle glaucoma or ocular hypertension.
The primary aim of this study is to show that IOP reduction between the two formulations is
equivalent at the end of the 4 week treatment period.
Efficacy and Safety of Travoprost 0.004% Versus Tafluprost 0.0015% in Patients With Primary Open-angle Glaucoma or Ocular Hypertension
Completed
Alcon Research
Phase 4
2009-09-01
The purpose of this study is to assess the safety and efficacy of Travoprost 0.004% and
Tafluprost 0.0015% in patients with primary open angle glaucoma or ocular hypertension when
both medications are administered in the evening.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.
